ArticleVirus research2026
Foot-and-mouth disease virus 3D polymerase antagonizes the interferon signaling pathway by blocking STAT2 nuclear translocation.
Article in Virus research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
- Erratum issued
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Foot-and-mouth disease virus (FMDV) is the etiological agent of foot-and-mouth disease (FMD), which is highly contagious and extremely destructive in cloven-hoofed animals. Previous studies have shown that FMDV strongly suppress the innate immune response, and the research mainly focused on FMDV 3C and L proteinase. However, the role of FMDV 3D polymerase, an RNA-dependent RNA polymerase (RdRp), in inhibiting the IFN signaling pathway remains unclear. In this study, for the first time, we demonstrate that the highly conserved 3D polymerase of FMDV inhibits the activation of the JAK-STAT signaling pathway by targeting STAT2. Mechanistically, FMDV 3D significantly inhibits the activity of the interferon-stimulated response element promoter and downregulates the transcription of interferon-stimulated genes. Further research revealed that 3D interacts with STAT2, hinders its phosphorylation, and inhibits its nuclear translocation, thereby blocking the activation of the JAK-STAT signaling pathway. Collectively, these findings elucidate a novel mechanism by which FMDV 3D polymerase, acting as an inhibitor, targets STAT2 to suppress IFN signaling and antagonize the host antiviral immune response. This will provide insights for the development of future anti-FMDV strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.